{"id":"https://openalex.org/W4361950737","doi":"https://doi.org/10.1158/1078-0432.c.6521418.v1","title":"Data from Neutrophils Promote the Malignant Glioma Phenotype through S100A4","display_name":"Data from Neutrophils Promote the Malignant Glioma Phenotype through S100A4","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361950737","doi":"https://doi.org/10.1158/1078-0432.c.6521418.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6521418.v1","doi":"https://doi.org/10.1158/1078-0432.c.6521418.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6521418.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6521418.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100408927","display_name":"Ji Liang","orcid":"https://orcid.org/0000-0002-9295-2345","observed_orcids":["https://orcid.org/0000-0002-9295-2345"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ji Liang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110010918","display_name":"Yuji Piao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuji Piao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052224699","display_name":"Lindsay Holmes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lindsay Holmes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012403937","display_name":"Gregory N. Fuller","orcid":"https://orcid.org/0000-0001-9447-2647","observed_orcids":["https://orcid.org/0000-0001-9447-2647"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory N. Fuller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110562054","display_name":"Verlene K. Henry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Verlene Henry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088363363","display_name":"Ningyi Tiao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ningyi Tiao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5021372827","display_name":"John F. de Groot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John F. de Groot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.6826000213623047,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.6826000213623047,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.17489999532699585,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.06210000067949295,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neutrophils","display_name":"neutrophils","score":0.9580000042915344},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.8519999980926514},{"id":"https://openalex.org/keywords/s100a4","display_name":"S100A4","score":0.9760000109672546},{"id":"https://openalex.org/keywords/anti-vegf-therapy-resistance","display_name":"anti-VEGF therapy resistance","score":0.9169999957084656},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8479999899864197},{"id":"https://openalex.org/keywords/cancer-stem-cells","display_name":"cancer stem cells","score":0.6600000262260437},{"id":"https://openalex.org/keywords/mesenchymal-phenotype","display_name":"mesenchymal phenotype","score":0.7699999809265137},{"id":"https://openalex.org/keywords/tumor-progression","display_name":"tumor progression","score":0.6620000004768372},{"id":"https://openalex.org/keywords/neutrophil-infiltration","display_name":"neutrophil infiltration","score":0.8360000252723694},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.774864673614502},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6483467817306519},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.6468147039413452},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5957567095756531},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.41351577639579773},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3861857056617737},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33945202827453613},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.323600709438324},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11978450417518616},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6521418.v1","doi":"https://doi.org/10.1158/1078-0432.c.6521418.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6521418.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6521418.v1","doi":"https://doi.org/10.1158/1078-0432.c.6521418.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6521418.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2164871149","https://openalex.org/W2766685632","https://openalex.org/W4283801931","https://openalex.org/W3011177832","https://openalex.org/W2767472237","https://openalex.org/W2109010458","https://openalex.org/W4361950044","https://openalex.org/W7127376998","https://openalex.org/W2320223027","https://openalex.org/W4416139766"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Antiangiogenic":[2],"therapy":[3,180,195,240],"is":[4,94,209,218],"effective":[5,229],"in":[6,19,63,66,89,101,167,170,181],"blocking":[7],"vascular":[8,11],"permeability,":[9],"inhibiting":[10],"proliferation,":[12],"and":[13,65,68,100,114,149,169,199,225,237],"slowing":[14],"tumor":[15,159],"growth,":[16],"but":[17],"studies":[18],"multiple":[20],"cancer":[21],"types":[22],"have":[23],"shown":[24],"that":[25,86,112,188],"tumors":[26,93],"eventually":[27],"acquire":[28],"resistance":[29,42,105],"to":[30,106,146,231],"blockade":[31],"of":[32,57,122,178,191,216],"blood":[33],"vessel":[34],"growth.":[35],"Currently,":[36],"the":[37,55,76,119,176,214,233],"mechanisms":[38],"by":[39,72,164,212,220],"which":[40,73,217],"this":[41,51,139],"occurs":[43],"are":[44],"not":[45],"well":[46],"understood.":[47],"Experimental":[48],"Design:":[49],"In":[50,126],"study,":[52],"we":[53],"evaluated":[54],"effects":[56],"neutrophils":[58,74,113,128,143,192],"on":[59],"glioma":[60,78,98,197,234],"biology":[61],"both":[62],"vitro":[64,168],"vivo":[67],"determined":[69],"target":[70],"genes":[71],"promote":[75,201],"malignant":[77,235],"phenotype":[79,236],"during":[80,193],"anti-VEGF":[81,107,179,194],"therapy.":[82,108],"Results:":[83],"We":[84],"found":[85],"an":[87],"increase":[88],"neutrophil":[90,221],"infiltration":[91],"into":[92],"significantly":[95,129],"correlated":[96],"with":[97,103,135,138,142,154,206],"grade":[99],"glioblastoma":[102],"acquired":[104],"Our":[109],"data":[110,186],"demonstrate":[111],"their":[115],"condition":[116],"media":[117],"increased":[118,130,175,189,219],"proliferation":[120],"rate":[121],"glioblastoma-initiating":[123],"cells":[124],"(GIC).":[125],"addition,":[127],"GICs":[131,145],"Transwell":[132],"migration":[133],"compared":[134],"controls.":[136],"Consistent":[137],"behavior,":[140],"coculture":[141],"promoted":[144],"adopt":[147],"morphologic":[148],"gene":[150],"expression":[151,215],"changes":[152],"consistent":[153],"a":[155],"mesenchymal":[156,207],"signature.":[157],"Neutrophil-promoting":[158],"progression":[160,198,205],"could":[161],"be":[162,228],"blocked":[163],"S100A4":[165,173,226],"downregulation":[166],"vivo.":[171],"Furthermore,":[172],"depletion":[174],"effectiveness":[177],"glioma.":[182],"Conclusions:":[183],"Collectively,":[184],"these":[185],"suggest":[187],"recruitment":[190],"promotes":[196],"may":[200,227],"treatment":[202],"resistance.":[203,241],"Tumor":[204],"characteristics":[208],"partly":[210],"mediated":[211],"S100A4,":[213],"infiltration.":[222],"Targeting":[223],"granulocytes":[224],"approaches":[230],"inhibit":[232],"diminish":[238],"antiangiogenic":[239],"Clin":[242],"Cancer":[243],"Res;":[244],"20(1);":[245],"187\u201398.":[246],"\u00a92013":[247],"AACR.":[248]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-05T00:00:00"}